129 related articles for article (PubMed ID: 27206940)
21. Use of Statin and Target Low-density lipoprotein cholesterol attainment among post-ST elevation myocardial infarction patients in Shahid Gangalal National Heart Centre, Kathmandu, Nepal.
Adhikari CM; Prajapati D; Timalsena B; Bogati A; Khan B; Safi S; Adhikari J; Ghimire V
J Nepal Health Res Counc; 2024 Mar; 21(4):564-572. PubMed ID: 38616584
[TBL] [Abstract][Full Text] [Related]
22. Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor-containing regimen.
Marzolini C; Cavassini M; Braun DL; Hachfeld A; Bernasconi E; Calmy A; Schmid P; Battegay M; Elzi L;
Br J Clin Pharmacol; 2023 Sep; 89(9):2739-2746. PubMed ID: 37101315
[TBL] [Abstract][Full Text] [Related]
23. Effect of Switching from Low-Dose Simvastatin to High-Dose Atorvastatin on Glucose Homeostasis and Cognitive Function in Type 2 Diabetes.
Thongtang N; Tangkittikasem N; Samaithongcharoen K; Piyapromdee J; Srinonprasert V; Sriussadaporn S
Vasc Health Risk Manag; 2020; 16():367-377. PubMed ID: 33061398
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of subjects with very low serum low-density lipoprotein cholesterol and the risk for intracerebral hemorrhage.
Lee JG; Koh SJ; Yoo SY; Yu JR; Lee SA; Koh G; Lee D
Korean J Intern Med; 2012 Sep; 27(3):317-26. PubMed ID: 23019397
[TBL] [Abstract][Full Text] [Related]
25. Adherence to Current Dyslipidemia Guideline in Patients Utilizing Statins According to Risk Groups and Gender Differences: The AIZANOI Study.
Şen T; Dinç Asarcıklı L; Güven S; Kocabaş U; Özgeyik M; Demir M; Oskay T; Durmuş Hİ; Kalaycı B; Çelik MC; Kahraman F; Utku Ö; Astarcıoğlu MA; Yılmaz S; Tunçez A
Anatol J Cardiol; 2024 Jun; 28(6):273-282. PubMed ID: 38829258
[TBL] [Abstract][Full Text] [Related]
26. Lower intensified target LDL-c level of statin therapy results in a higher risk of incident diabetes: a meta-analysis.
Cai R; Yuan Y; Zhou Y; Xia W; Wang P; Sun H; Yang Y; Huang R; Wang S
PLoS One; 2014; 9(8):e104922. PubMed ID: 25122464
[TBL] [Abstract][Full Text] [Related]
27. Statins-Their Role in Bone Tissue Metabolism and Local Applications with Different Carriers.
Granat MM; Eifler-Zydel J; Kolmas J
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397055
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus.
Kong SH; Koo BK; Moon MK
Diabetes Metab J; 2017 Feb; 41(1):23-30. PubMed ID: 28029012
[TBL] [Abstract][Full Text] [Related]
29. A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) study.
Bohn B; Lutsey PL; Tang W; Pankow JS; Norby FL; Yu B; Ballantyne CM; Whitsel EA; Matsushita K; Demmer RT
J Proteomics; 2023 Feb; 272():104788. PubMed ID: 36470581
[TBL] [Abstract][Full Text] [Related]
30. Low- and High-Density Lipoprotein Cholesterol and Dementia Risk Over 17 Years of Follow-up Among Members of a Large Health Care Plan.
Ferguson EL; Zimmerman SC; Jiang C; Choi M; Swinnerton K; Choudhary V; Meyers TJ; Hoffmann TJ; Gilsanz P; Oni-Orisan A; Whitmer RA; Risch N; Krauss RM; Schaefer CA; Glymour MM
Neurology; 2023 Nov; 101(21):e2172-e2184. PubMed ID: 37793911
[TBL] [Abstract][Full Text] [Related]
31. Assessing appropriateness of lipid management among patients with diabetes mellitus: moving from target to treatment.
Beard AJ; Hofer TP; Downs JR; Lucatorto M; Klamerus ML; Holleman R; Kerr EA;
Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):66-74. PubMed ID: 23233749
[TBL] [Abstract][Full Text] [Related]
32. Impact of predictors upon the reduction of lipid parameters in family medicine practice.
Doganer YC; Angstman K; Rohrer J; Merry S
Sao Paulo Med J; 2015; 133(5):428-34. PubMed ID: 26648432
[TBL] [Abstract][Full Text] [Related]
33. Intensity of statin therapy and primary prevention of cardiovascular in Korean patients with dyslipidemia.
Song SO; Kang MJ; Suh S
Medicine (Baltimore); 2024 Mar; 103(11):e37536. PubMed ID: 38489707
[TBL] [Abstract][Full Text] [Related]
34. Statin treatment in stroke patient with low-density lipoprotein cholesterol levels below 70 mg/dL.
Lee KP; Huang HC; Tsai JY; Hsu LC
J Stroke Cerebrovasc Dis; 2024 May; 33(5):107645. PubMed ID: 38395098
[TBL] [Abstract][Full Text] [Related]
35. Significant Gap Between Guidelines and Practice in the Management of LDL Cholesterol: Insight From the Survey of the Korean Society of Myocardial Infarction.
Lee SY; Cho KH; Lee JH; Hong YJ; Hwang JY; Jeong MH; Kim W
J Korean Med Sci; 2023 Dec; 38(50):e419. PubMed ID: 38147840
[TBL] [Abstract][Full Text] [Related]
36. Racial Differences in the Cholesterol-Lowering Effect of Statin.
Naito R; Miyauchi K; Daida H
J Atheroscler Thromb; 2017 Jan; 24(1):19-25. PubMed ID: 27733728
[TBL] [Abstract][Full Text] [Related]
37. Barriers to non-HDL cholesterol goal attainment by providers.
Virani SS; Steinberg L; Murray T; Negi S; Nambi V; Woodard LD; Bozkurt B; Petersen LA; Ballantyne CM
Am J Med; 2011 Sep; 124(9):876-80.e2. PubMed ID: 21854896
[TBL] [Abstract][Full Text] [Related]
38. Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs.
Patel KK; Kashfi K
Biochem Pharmacol; 2022 Feb; 196():114654. PubMed ID: 34129857
[TBL] [Abstract][Full Text] [Related]
39. Effect of low-density lipoprotein level and mortality in older incident statin-naïve hemodialysis patients.
Song JH; Park EH; Bae J; Kwon SH; Cho JH; Yu BC; Han M; Song SH; Ko GJ; Yang JW; Chung S; Hong YA; Hyun YY; Bae E; Sun IO; Kim H; Hwang WM; Shin SJ; Park WY; Kim H; Yoo KD
BMC Nephrol; 2023 Oct; 24(1):289. PubMed ID: 37784041
[TBL] [Abstract][Full Text] [Related]
40. Association Between Age and Low-Density Lipoprotein Cholesterol Response to Statins : A Danish Nationwide Cohort Study.
Corn G; Melbye M; Hlatky MA; Wohlfahrt J; Lund M
Ann Intern Med; 2023 Aug; 176(8):1017-1026. PubMed ID: 37523692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
